# Engineering Immune Organoids to Study Pediatric Cancer

> **NCT05890781** · NA · RECRUITING · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 108 (estimated)

## Conditions studied

- Brain Tumor
- Kidney Tumor
- Neuroblastoma
- Sarcoma

## Interventions

- **PROCEDURE:** Skin biopsy
- **PROCEDURE:** Fresh tumor sample
- **BIOLOGICAL:** Blood sample
- **PROCEDURE:** Healthy tissue from the tumor
- **PROCEDURE:** Spinal cerebrospinal fluid (SCF)

## Key facts

- **NCT ID:** NCT05890781
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-12
- **Primary completion:** 2028-05
- **Final completion:** 2028-05
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05890781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05890781, "Engineering Immune Organoids to Study Pediatric Cancer". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05890781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*